CA3299931A1 - Formes solides de gusacitinib - Google Patents

Formes solides de gusacitinib

Info

Publication number
CA3299931A1
CA3299931A1 CA3299931A CA3299931A CA3299931A1 CA 3299931 A1 CA3299931 A1 CA 3299931A1 CA 3299931 A CA3299931 A CA 3299931A CA 3299931 A CA3299931 A CA 3299931A CA 3299931 A1 CA3299931 A1 CA 3299931A1
Authority
CA
Canada
Prior art keywords
gusacitinib
solid state
state forms
forms
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3299931A
Other languages
English (en)
Inventor
Scott Kevin Thompson
Dingding JING
Yaqi SHANG
Qi Zhang
Jun Xue
Original Assignee
Libertas Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Libertas Bio Inc filed Critical Libertas Bio Inc
Publication of CA3299931A1 publication Critical patent/CA3299931A1/fr
Pending legal-status Critical Current

Links

CA3299931A 2023-07-27 2024-07-26 Formes solides de gusacitinib Pending CA3299931A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNPCT/CN2023/109559 2023-07-27

Publications (1)

Publication Number Publication Date
CA3299931A1 true CA3299931A1 (fr) 2025-01-30

Family

ID=

Similar Documents

Publication Publication Date Title
EP4165031A4 (fr) Formes solides de cyantraniliprole
EP4271402A4 (fr) Composition de bl-8040
CA3261296A1 (fr) Variants de tdp-43 résistants à l'agrégation
AU2024372206A1 (en) Solid state forms of deutivacaftor
CA3303749A1 (fr) Formes à l'état solide de samuraciclib
CA3299931A1 (fr) Formes solides de gusacitinib
CA3299990A1 (fr) Formes à l'état solide de gusacitinib
CA3297108A1 (fr) Formes à l'état solide de sunvozertinib
CA3294911A1 (fr) Formes à l'état solide de rencofilstat
CA3268966A1 (fr) Formes à l'état solide de denifanstat
CA3283729A1 (fr) Forme à l'état solide de pirtobrutinib
CA3292360A1 (fr) Utilisation de micro-peptide miac
CA3268997A1 (fr) Formes à l'état solide de sels de cilofexor
CA3275080A1 (fr) Formes solides co-amorphes de flavonoides
HK40127094A (en) Solid forms of rxfp1 modulators
IL326153A (en) Solid state forms of GUSACITINIB
IL326152A (en) Solid state forms of GUSACITINIB
IL319179A (en) Solid forms of Dinipenstat
AU2024250756A1 (en) Immunology of hydroxy-pyrrolones
CA3281723A1 (fr) Immunologie d'hydroxy-pyrrolones
HK40122949A (en) Modified release of ascarosides
CA3291219A1 (fr) Formulations de pectolinarigénine
CA3288524A1 (fr) Formes cristallines d'événamide
CA3266364A1 (fr) Utilisation d'un composé hétéroaryloxynaphtalène
HK40109191A (en) Solid forms of (r)-oxybutynin d-malate